Clinical data | |
---|---|
Other names | LA-CH2CF3 |
Identifiers | |
| |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C20H22F3N3O |
Molar mass | 377.411 g·mol−1 |
3D model (JSmol) | |
| |
|
ETFELA (N-ethyl-N-(2,2,2-trifluoroethyl)lysergamide) is an analogoflysergic acid diethylamide (LSD) first synthesised by Jason C. Parrish as part of the research team led by David E. Nichols. In studies in vitro, it was found to be slightly more potent than LSD itself.[1][2]
| |
---|---|
Lysergic acid derivatives |
|
Psychedelic lysergamides |
|
Clavines |
|
Other ergolines |
|
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |
This hallucinogen-related article is a stub. You can help Wikipedia by expanding it. |